Markolf Hanefeld — ASN Events

Presentations this author is a contributor to:

Advancing Basal Insulin Glargine with Prandial Lixisenatide QD vs Insulin Glulisine QD or TID in T2DM: The GetGoal-Duo2 Evidence-Based Trial (NCT01768559) (#166)